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Abstract: Phytochemicals, such as monoterpenes, polyphenols, curcuminoids, and flavonoids, are known
to have anti-inflammatory, antioxidant, neuroprotective, and procognitive effects. In this study, the effects
of several polyhydroxy flavonoids, as derivatives of differently substituted 5,7-dihydroxy-4H-chromen4-one including apigenin, genistein, luteolin, kaempferol, quercetin, gossypetin, and phloretin with
different lipophilicities (cLogP), as well as topological polar surface area (TPSA), were tested for
induction of Ca2+ transients by α7 human nicotinic acetylcholine (α7 nACh) receptors expressed
in SH-EP1 cells. Apigenin (10 µM) caused a significant potentiation of ACh (30 µM)-induced Ca2+
transients, but did not affect Ca2+ transients induced by high K+ (60 mM) containing solutions.
Co-application of apigenin with ACh was equally effective as apigenin preincubation. However,
the effect of apigenin significantly diminished by increasing ACh concentrations. The flavonoids
tested also potentiated α7 nACh mediated Ca2+ transients with descending potency (highest to lowest) by genistein, gossypetin, kaempferol, luteolin, phloretin, quercetin, and apigenin. The specific
binding of α7 nACh receptor antagonist [125 I]-bungarotoxin remained unchanged in the presence of
any of the tested polyhydroxy flavonoids, suggesting that these compounds act as positive allosteric
modulators of the α7-nACh receptor in SH-EP1 cells. These findings suggest a clinical potential for
these phytochemicals in the treatment of various human diseases from pain to inflammation and
neural disease.
Keywords: nicotinic receptors; apigenin; flavonoids; positive allosteric modulator; pain; inflammation; neurodegenerative disorders
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1. Introduction
Nicotinic acetylcholine (nACh) receptors belong to the ligand-gated ion channel family that includes serotonin type-3, glycine, and γ-aminobutyric acid (GABA)-A receptors.
The homomeric α7 nACh receptor subtype is expressed in both central and peripheral
nervous systems, as well as non-neuronal cells, and plays an important role in synaptic plasticity and various disease pathologies [1]. Thus, α7-nACh receptors are recognized targets
for drug development in several preclinical experimental models of pain, inflammation,
neurodegenerative diseases, and psychosis [1,2]. Therefore, chemical entities modulating
the function these receptors have clinical significance in treating pain and inflammation,
and alleviating several neurodegenerative disorders.
Phytochemicals, such as terpenes, polyphenols, curcuminoids, and flavonoids, have been
shown extensively to exert antioxidant, anti-inflammatory, anti-hypertensive, neuroprotective, antiepileptic, and procognitive effects [3–7]. In search of new compounds, several
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Phytochemicals, such as terpenes, polyphenols, curcuminoids, and flavonoids, have
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been shown extensively to exert antioxidant, anti-inflammatory, anti-hypertensive,
neuroprotective, antiepileptic, and procognitive effects [3–7]. In search of new
compounds, several phytochemicals including terpenes, such as menthol [8], thujone [9],
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2. Materials
Materials and
and Methods
Methods
2.1. Cell Culturing
2.1. Cell Culturing
Culturing of SH-EP1 cells [24] and stable transfection methods used to produce
Culturing of SH-EP1 cells [24] and stable transfection methods used to produce this
this cell line were described earlier [25]. Briefly, Dulbecco’s modified Eagle’s medium
cell line were described earlier [25]. Briefly, Dulbecco’s modified Eagle’s medium
supplemented with 10% heat inactivated horse serum, 5% fetal bovine serum, 100 U/mL
supplemented with 10% heat inactivated horse serum, 5% fetal bovine serum, 100 U/mL
penicillin G, 100 µg/mL streptomycin, 0.25 µg/mL amphotericin B, 0.4 mg/mL hygromycin
penicillin G, 100 μg/mL streptomycin, 0.25 μg/mL amphotericin B, 0.4 mg/mL hygromycin
B, 0.25 mg/mL Zeocin, and 1 mM sodium pyruvate (all from Invitrogen, Carlsbad, CA,
B, 0.25 mg/mL Zeocin, and 1 mM sodium pyruvate (all from Invitrogen, Carlsbad, CA,
USA) were used to grow SH-EP1 cells on 35 mm dishes. Subsequently, cells were plated at
USA) were used to grow SH-EP1 cells on 35 mm dishes. Subsequently, cells were plated
a density of 2 × 105 cells
per well into 96-well plates and were held for 2–3 days in 5% CO2
at a density of 2 × 105 cells per well into 96-well plates and were held for 2–3 days in 5%
saturated with H2 O at 37 ◦ C.
CO2 saturated with H2O at 37 °C.
2.2. Intracellular [Ca2+ ] Measurements
2.2. Intracellular [Ca2+] Measurements
These experiments were conducted as described earlier [9,14] at room temperature
experiments
were
as with
described
[9,14]
at room temperature
(24 ±These
2 ◦ C). Briefly,
SH-EP1
cellsconducted
were loaded
10 µMearlier
fluo-4 AM
(Molecular
Probes, Life
(24
±
2
°C).
Briefly,
SH-EP1
cells
were
loaded
with
10
μM
fluo-4
AM
(Molecular
Probes,
Technologies, Paisley, UK) in Krebs-HEPES solution (in mM: 144 NaCl, 5.9
KCl, 1.2 MgCl
2,
◦
Life
Technologies,
Paisley,
UK)
in
Krebs-HEPES
solution
(in
mM:
144
NaCl,
5.9
KCl,
1.2
2 CaCl2 , 11 D-glucose, 10 HEPES, pH 7.4) for 45 min at 37 C in the dark. Next, fluo-4
AM loaded cells were washed twice with Krebs-HEPES at room temperature. All test
and incubation solutions contained atropine (1 µM). Fluorescence changes (excitation
485 nm, emission 520 nm) were measured using a fluorescent plate reader (Fluostar, BMG
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Labtech Inc., Cary, NC, USA). Changes in basal fluorescence levels were monitored before
and after adding ACh containing solution through an automatic dispenser. Fluorescence
changes were recorded for 30 s. The responses from each well were calibrated by measuring
maximum and minimum fluorescence values to normalize fluo-4 signals. The Fmax value
was obtained by the addition of 75 µL of 5% Triton X-100 and Fmin was attained by
addition of 50 µL of 1 M MnCl2 at the end of the experiment. Data were presented as a
percentage (%) of Fmax–Fmin or area under fluorescence curve (AUC). Apigenin, genistein,
gossypetin, kaempferol, luteolin, phloretin, and quercetin were purchased from Sigma
(Sigma, St. Louis, MO, USA). Flavonoids were dissolved in DMSO. At final concentrations
of 0.01%, DMSO did not affect ACh-induced Ca2+ transient (n = 4).
2.3. Radioligand Binding Experiments
In 35 mm dishes, the SH-EP1 cells were grown to confluence, collected by scraping
in 50 mM HEPES buffer solution containing 1 mM MgCl2 , 2.5 mM CaCl2 , 0.1% (w/v)
bovine serum albumin, 0.025% (w/v) bacitracin, and 0.025% (w/v) sodium azide (pH 7.4),
and centrifuged at 1200 r.p.m. for 15 min at 4 ◦ C. Subsequently, the supernatant was
removed and cells were frozen at −80 ◦ C until the day of the experiment. For binding
assays, using a Polytron tissue homogenizer at setting 4 for 20 s, the cells were resuspended
in 50 mM Tris-HCl buffer containing 120 mM NaCl, 5 mM EDTA, 1.5 mM MgCl2 , and 5 mM
KCl (pH 7.4). In a total of 250 µL volume, 150 µL cell suspension, 50 µL radioligand [125 I]α-bungarotoxin (2200 Ci/mmol; Perkin-Elmer, Inc. Waltham, MA, USA) and 50 µL test
compound, were added to 96-well microtitre plates. The α-bungarotoxin (3 µM) was used
to determine non-specific binding. Subsequent to 45 min incubation at room temperature,
the plates were filtered through Packard Unifilter-96, GF/C plates and washed twice with
500 µL ice-cold 10 mM Tris-HCl buffer containing 150 mM NaCl (pH 7.4). The radioactivity
bound to filters was counted in 50 µL of scintillation solution (MicroScint 40, PerkinElmer, Inc. Waltham, MA, USA) in Packard TopCount scintillation counter. Assays were
performed in triplicate.
2.4. Metric Parameters and Drug-Likeness Properties
Molecular weight (MW), water solubility (clogS), and Lipophilicity (clogP) of Lipinski’s rule for drug-likeness were calculated using the computational tool Osiris Property explorer. (Molinspiration software or free molecular property calculation services
(last accessed 23 February 2021)) and Molinspiration property calculation toolkit [22,23].
The observed metric parameters for the tested polyphenol flavonoids are summarized in
Table 1.
Table 1. Drug-likeness calculations and Lipinski parameters for tested polyphenol flavonoids.
a molecular weight, b topological polar surface area, c water solubility (clogS), d lipophilicity (clogP),
e Molinspiration software or free molecular property calculation services (Molinspiration software or
free molecular property calculation services (last accessed 23 February 2021)).
Compound

MW a

TPSA b

cLogS c

cLogP d

Drug-Likeness
Model Score e

Apigenin
Genistein
Luteolin
Kaempferol
Quercetin
Gossypetin
Phloretin

270.24
270.24
286.24
286.24
302.24
318.24
258.27

90.89
86.99
111.12
107.21
131.35
127.42
77.75

−2.86
−2.73
−2.56
−2.79
−2.49
−2.19
−2.52

2.34
1.63
1.99
1.84
1.49
1.14
2.04

1.21
1.16
1.91
0.91
1.64
0.67
−0.56
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Phloretin

258.27

77.75

−2.52

2.04

4 of 8

−0.56

2.5. Statistical Analysis
2.5. Statistical Analysis

The mean ± standard error means (S.E.M.) was used to present data. Statistical signifiThe mean ± standard error means (S.E.M.) was used to present data. Statistical
cance between measurements in different groups was determined using One-way ANOVA.
significance between measurements in different groups was determined using One-way
When differences
were found,
post-hoc
comparisons
usingusing
the Bonferroni
correcANOVA.
When differences
were pair-wise
found, pair-wise
post-hoc
comparisons
the
tion
were
applied.
The
p
values
<
0.05
were
considered
significant.
Radioligand
saturation
Bonferroni correction were applied. The p values < 0.05 were considered significant.
curves weresaturation
obtainedcurves
by fitting
data to
logistic
equation,
using equation,
non-linear hyperbolic
Radioligand
werethe
obtained
bythe
fitting
the data
to the logistic
using
hyperbolic
curve fitting
of OriginPro
(OriginLab Corp.,
curvenon-linear
fitting function
of OriginPro
8.5function
(OriginLab
Corp., 8.5
Northampton,
MA, USA).
Northampton, MA, USA).

3. Results

3. Results

In preliminary experiments, no detectable changes in intracellular Ca2+ levels were

In preliminary experiments, no detectable changes in intracellular Ca2+ levels were
observed after 30 s application of apigenin alone (up to 100 µM) in Fluo-4 loaded SHobserved after 30 s application of apigenin alone (up to 100 μM) in Fluo-4 loaded SH-EP1
EP1 (n
cells
(n from
= 11 3from
3 separate
experiments).
On hand,
the other
rapid
cells
= 11
separate
experiments).
On the other
rapidhand,
increases
in increases in
2+ concentrations were consistently observed following the application
2+
intracellular
Ca
intracellular Ca concentrations were consistently observed following the application of
2+ transients were 2+
30
acetylcholine
(ACh) (Figure
control).
These
ACh-induced
of μM
30 µM
acetylcholine
(ACh)2A,
(Figure
2A,
control).
These Ca
ACh-induced
Ca transients
completely
inhibited
after
5
min
pre-incubation
with
methyllycaconitine
(10
μM),
a
were completely inhibited after 5 min pre-incubation with methyllycaconitine
(10 µM),
selective
antagonist
for
α7-nACh
receptor
(Figure
2A).
a selective antagonist for α7-nACh receptor (Figure 2A).

Figure
effects
of apigenin
on Ca2+on
transients
elicited by elicited
the stimulation
human α7 nACh
Figure2.2.The
The
effects
of apigenin
Ca2+ transients
by theofstimulation
of human α7 nACh
receptors expressed in SH-EP1 cells. (A) The effect of 10 μM apigenin and 10 μM
receptors
expressed
in
SH-EP1
cells.
(A)
The
effect
of
10
µM
apigenin
and
10
µM
methyllycaconitine
2+
methyllycaconitine (MLA) on Ca transients induced by 30 μM ACh in 10 μM Fluo-4 AM loaded
SH-EP1
(B)2+Cumulative
of apigenin
and ACh
MLA in
on 10
theµM
areaFluo-4
under curve
(AUC) ofSH-EP1
Ca2+
(MLA) cells.
on Ca
transientseffects
induced
by 30 µM
AM loaded
cells. (B) Cu2+
transients
induced
by
ACh.
Bars
indicate
the
mean
±
S.E.M.
*
indicates
p
<
0.05
(ANOVA,
n=
14–
mulative effects of apigenin and MLA on the area under curve (AUC) of Ca transients induced
17). (C) The effect of preincubation time on the apigenin potentiation of Ca2+ transients induced by
by ACh.
Bars
indicate
mean
± S.E.M.
indicates
p < 0.05 (ANOVA,
ACh
(n = 9–12;
ANOVA,
p >the
0.05).
(D) The
effect of *increasing
concentrations
of ACh onn=
the14–17). (C) The effect
of preincubation
time on of
the
apigenin
potentiation
of Ca2+ Bars
transients
indicateinduced
the mean by
% ACh (n = 9–12;
apigenin
(10 μM) potentiation
ACh
(30 μM)-induced
Ca2+ transients.
potentiation
S.E.M.
n = (D)
11–15.
ANOVA, p± >
0.05).
The effect of increasing concentrations of ACh on the apigenin (10 µM)

potentiation of ACh (30 µM)-induced Ca2+ transients. Bars indicate the mean % potentiation ± S.E.M.
Five min. pre-incubation of cells with 10 μM apigenin caused a significant
n = 11–15. (48% ± 5, n = 14, ANOVA, p = 0.001) of the ACh-induced Ca2+ transients
potentiation

Five min. pre-incubation of cells with 10 µM apigenin caused a significant potentiation
(48% ± 5, n = 14, ANOVA, p = 0.001) of the ACh-induced Ca2+ transients (Figure 2A,B).
Notably, a 5 min. application of 10 µM apigenin did not change the magnitude of the Ca2+
transient induced by the application of high-K+ (60 mM KCl, n = 11, ANOVA, p = 0.634),
suggesting that the effects of apigenin are not due to the activity of voltage-dependent
Ca2+ channels. Since most of the phytochemical effects were previously shown to be
enhanced by the duration of the pre-application [8–12], we compared the effects of 5 min,
2 min, and 30 s apigenin pre-application, and also examined the effect of co-application
of apigenin and ACh. The extent of apigenin potentiation of ACh-induced Ca2+ transient
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was found unchanged (Figure 2C) under various pre-application, as well as co-application
time conditions. In earlier studies with curcumin, we observed that its potentiating effect was significantly diminished with increasing agonist concentrations [15]. Therefore,
we tested the effect of increasing ACh concentration on apigenin potentiation of the Ca2+
transient. Interestingly, the effect of apigenin was significantly decreased at higher ACh
concentrations (Figure 2D).
Next, we investigated the effects of the other polyhydroxy flavonoids genistein,
gossypetin, kaempferol, luteolin, phloretin, and quercetin on ACh-induced Ca2+ transients
in the same cell line. No detectable changes in intracellular Ca2+ levels were observed after
30 s applications of these flavonoids alone (up to 30 µM) in Fluo-4 loaded SH-EP1 cells
(n = 7–12 from 4 separate experiments). At 10 µM, all flavonoids tested caused a significant
potentiation of ACh (30 µM)-induced Ca2+ transients (Figure 3A), with a potency profile of:
6 of 9
phloretin (112% ± 12) > genistein (83% ± 7) ≥ kaempferol (81% ± 8) > quercetin
(73% ± 6)
≥ luteolin (72% ± 5) > gossypetin (65% ± 4).

125I] α2+ transients
Figure
3. The
of flavonoids
on the Ca2+on
transients
by AChinduced
and specific
Figure
3. effect
The effect
of flavonoids
the Cainduced
by[ ACh
and specific [125 I] αbungarotoxin binding in SH-EP1 cells. (A) The effect of 10 μM of genistein, gossypetin,
bungarotoxin binding in SH-EP1 cells. (A) The effect of 10 µM of genistein, gossypetin, kaempferol,
kaempferol, luteolin, phloretin, and quercetin on ACh (30 μM)-induced intracellular Ca2+
2+ transients. Bars indicate
luteolin,Bars
phloretin,
quercetin
onnACh
(30 (B)
µM)-induced
Ca
transients.
indicateand
the mean
± S.E.M.
= 12–17.
The effect of intracellular
apigenin on the
binding
125I] α-bungarotoxin. Increasing concentrations of [125I] α-bungarotoxin are shown in
saturation
of
[
the mean ± S.E.M. n = 12–17. (B) The effect of apigenin on the binding saturation of [125 I] αX-axis as free ligand. SH-EP1 cells were incubated for125
45 min. with the indicated concentrations of
bungarotoxin. Increasing concentrations of [ I] α-bungarotoxin are shown in X-axis as free ligand.
[125I] α-bungarotoxin in the absence (filled circles) and presence (open circles) of apigenin (10 μM).
SH-EP1bungarotoxin
cells were incubated
45 min.
with the
indicated
concentrations
[125 I] α-bungarotoxin
Unlabeled
(3 μM) wasfor
added
to incubation
buffer
to determine
non-specificof
binding
(nin
= 4–6)
Scatchard
analysis,
effects on
saturation
binding
of [125I] α-bungarotoxin.
the (C)
absence
(filled
circles)apigenin
and presence
(open
circles)
of apigenin
(10 µM). Unlabeled bungarotoxin
Units are fmol/mg protein and fmol/mg protein/nM for x and y axis, respectively. (D) Effects of
(3 µM) was added to incubation buffer to determine non-specific binding (n = 4–6) (C) Scatchard
flavonoids on the specific binding of 2 nM [125I] α-bungarotoxin
in the same cell line. Bars indicate
analysis,
apigenin
effects on saturation binding of [125 I] α-bungarotoxin. Units are fmol/mg protein
the
mean ± S.E.M.
n = 9–12.

and fmol/mg protein/nM for x and y axis, respectively. (D) Effects of flavonoids on the specific
In subsequent
studies,
we investigated
thesame
effectcell
of apigenin
specificthe
binding
binding
of 2 nM [125
I] α-bungarotoxin
in the
line. Barson
indicate
mean of
± S.E.M. n = 9–12.
[125I] α-bungarotoxin, a competitive antagonist of ACh at the α7-nACh receptor [1].
Saturation curves for [125I] α-bungarotoxin binding in the absence (controls) and presence
of apigenin are shown in Figure 3B. In SH-EP1 cells preincubated (45 min) with 10 μM
apigenin, there was no significant change in [125I] α-bungarotoxin binding. The apparent
affinity (KD) of the receptor for [125I] α-bungarotoxin was 1.18 ± 0.29 and 1.03 ± 0.32 pM for
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In subsequent studies, we investigated the effect of apigenin on specific binding
of [125 I] α-bungarotoxin, a competitive antagonist of ACh at the α7-nACh receptor [1].
Saturation curves for [125 I] α-bungarotoxin binding in the absence (controls) and presence
of apigenin are shown in Figure 3B. In SH-EP1 cells preincubated (45 min) with 10 µM
apigenin, there was no significant change in [125 I] α-bungarotoxin binding. The apparent
affinity (KD ) of the receptor for [125 I] α-bungarotoxin was 1.18 ± 0.29 and 1.03 ± 0.32 pM
for controls and apigenin, respectively (n = 14 in 3 experiments; ANOVA, p = 0.097). In line
with this finding, Scatchard analysis of saturation binding data indicated that Bmax values
in the absence and presence of apigenin (10 µM) were not changed significantly (Figure 3C).
The Bmax values were 1.73 ± 0.09 pmol/mg in controls and 1.71 ± 0.11 pmol/mg in
the presence of apigenin (n = 11 measurement from 3 experiments, ANOVA, p = 0.086).
Finally, we tested the effects of 10 µM genistein, gossypetin, kaempferol, luteolin, phloretin,
and quercetin on [125 I] α-bungarotoxin binding. Similarly to apigenin, these polyhydroxy
flavonoids did not change [125 I] α-bungarotoxin binding in SH-EP1 cells (Figure 3D).
4. Discussion
In the present study, we provide evidence that flavonoids, such as apigenin, genistein,
gossypetin, kaempferol, luteolin, phloretin, and quercetin, allosterically potentiate human
α7-nACh receptors expressed in SH-EP1 cells. In addition, we present some important
physicochemical parameters suggested to be useful in selecting oral drug candidates to facilitate drug discovery and development processes [22,26]. In this context, water-solubility
(clogS), lipophilicity (clogP), molecular weight (MW), drug-likeness score, and topological
polar surface area (TPSA), parameters closely related to Lipinski’s rule, were calculated for
the current panel of tested compounds (Figure 1) by applying the Osiris Property explorer
and the Molinspiration property calculation toolkit (Table 1) [26,27]. The clogS value indicating the drug solubility affects its absorption and distribution properties. Accordingly,
the solubility of the tested compounds was found in an acceptable range (<−4 clogS).
In addition to solubility, drug-likeness scores and the lipophilicity-related physicochemical
parameters, such as clogP, have been shown to modify drug potency, pharmacokinetics,
and toxicity, and are recognized as useful tools in the lead optimization process [21,23,26].
Consequently, ligands with a clogP < 5 were suggested to present more promising druglikeness profile [28,29]. Among the current panel of tested compounds, the clogP values
were calculated as <5 suggesting the suitability of the compounds for oral administration (Table 1). The TPSA values have also been used in development of a successful
drug candidate. In general, compounds with TPSA values > 60 Å2 are considered poorly
membrane-permeable molecules with relatively decreased CNS bioavailability [22,26].
Among the tested polyphenol flavonoids, the calculated TPSA values were in the range of
77–131 Å2 , suggesting physicochemical parameters expected from drug-like compounds,
especially regarding TPSA (Table 1). Another numerical value useful in drug development
process is the drug-likeness model score which signifies a combined result of physicochemical, pharmacokinetic, and pharmacodynamic properties of the compound [22].
Thus, ligands having zero or negative values are considered less suitable as a drug-like
candidate. In this study, all flavonoids, except for phloretin, have drug-likeness scores in
the range of 0.67–1.91; with apigenin, luteolin, and quercetin showing maximum-likeness
scores of 1.12, 1.91, 1.64, respectively (Table 1; Figure 1).
Preincubation with apigenin did not alter the extent of its effect, and co-application
with ACh was sufficient for potentiation of ACh-induced Ca2+ transients, suggesting
that membrane partitioning and/or the phosphorylation of the α7-nACh receptor are
not required for the observed effect. Importantly, positive modulatory effect of apigenin
was significantly diminished by increasing concentrations of ACh. It is possible that
desensitized α7-nACh receptors at high ACh concentrations have lower affinity to apigenin.
In line with this hypothesis, after complete desensitization of α7-nACh receptors with
(100 µM ACh for 1 min), apigenin failed to potentiate Ca2+ transients (data not shown,
n = 3).
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Moreover, other polyhydroxy flavonoids tested also potentiated ACh-induced Ca2+
transients with potency order of genistein > gossypetin > kaempferol > luteolin, phloretin,
and quercetin. Radioligand binding experiments indicate that apigenin and other flavonoids
does not alter [125 I] α-bungarotoxin binding suggesting that these compounds act as allosteric modulators of the α7-nACh receptor. These results confirm earlier findings with
genistein and quercetin [17–19], and identify apigenin, and other flavonoids, as likely
PAM of the human α7-nACh receptor. The PAMs are promising therapeutic agents since
they maintain the temporal and spatial characteristics of the endogenous activation of the
receptor and are usually more selective than agonists [1].
Combining these results, apigenin and structurally related other polyhydroxy flavonoids
revealed promising drug-likeness values, and underlined a role for polyphenol flavonoids in
the regulation of α7-nACh receptor signaling and their potential clinical use in conditions
ranging from the treatment of pain and inflammation to alleviating neurodegenerative
disorders.
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